Reported potential outcomes according to product type
| Product type | Potential outcome | ||||||
| Catastrophic | Major | Moderate | Minor | None | Not recorded | Total | |
| Cytotoxic adult | 1 (0.1%) | 49 (2.6%) | 53 (2.8%) | 249 (13.3%) | 1339 (71.7%) | 177 (9.5%) | 1868 |
| Cytotoxic paediatric | 0 | 2 (1.8%) | 6 (5.4%) | 34 (30.6%) | 63 (56.8%) | 6 (5.4%) | 111 |
| Parenteral nutrition—adult | 0 | 15 (2.2%) | 32 (4.7%) | 137 (20.1%) | 496 (72.8%) | 1 (0.1%) | 681 |
| Parenteral nutrition—paediatric | 1 (0.6%) | 21 (11.7%) | 18 (10.1%) | 47 (26.3%) | 88 (49.2%) | 4 (2.2%) | 179 |
| Other intravenous additive | 0 | 22 (1.7%) | 49 (3.8%) | 309 (24.1%) | 814 (63.5%) | 87 (6.8%) | 1281 |
| Other prefilled syringes | 2 (0.6%) | 7 (2.3%) | 22 (7.1%) | 48 (15.5%) | 218 (70.3%) | 13 (4.2%) | 310 |
| Other | 0 | 6 (2.8%) | 5 (2.3%) | 34 (15.7%) | 164 (75.6%) | 8 (3.7%) | 217 |
| Not recorded | 0 | 0 | 0 | 6 (13.6%) | 36 (81.8%) | 2 (4.5%) | 44 |
| Total | 4 (0.1%) | 122 (2.6%) | 185 (3.9%) | 864 (18.4%) | 3218 (68.6%) | 298 (6.4%) | 4691 |